Notable
Aegean · Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment · Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Recruitment opened
Athos Therapeutics IncPhase 2 NCT07513181 Registry history of NCT07513181 on ClinicalTrials.gov (opens the registry)